Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Germ Cell and Embryonal × Dactinomycin × 90 days × Clear all

Sponsor

Conditions

Rhabdomyosarcoma, Embryonal 2 Rhabdomyosarcoma 2 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Sarcoma, Ewing 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Rhabdomyosarcoma, Alveolar 1 Pleuropulmonary blastoma 1 Histiocytoma, Malignant Fibrous 1 Dermatofibrosarcoma 1

Interventions

fludarabine 3 Cyclophosphamide 3 fludarabine phosphate 2 Sirolimus 2 Etoposide 2 Cisplatin 2 Carboplatin 2 tremelimumab 1 pralsetinib 1 pembrolizumab 1 etoposide phosphate 1 durvalumab 1 cabozantinib 1 Surveys and Questionnaires 1 Stem Cell Transplantation 1 Standard of Care 1 Specimen Handling 1 Respiratory Physiological Phenomena 1 Proton Therapy 1 Practice Guidelines as Topic 1 Platinum 1 Pemetrexed 1 Paclitaxel 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Celecoxib 1 Busulfan 1 Bleomycin 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡